Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Findlow

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Human Vaccines & Immunotherapeutics|September 8, 2023
Real-world impact and effectiveness of MenACWY-TTRodolfo Villena, Paula Kriz, Myint Tin Tin Htar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2011
Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccinationJames B Wing, Lynne Smart, Ray Borrow, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2007
Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in EnglandCaroline Trotter, Jamie Findlow, Paul Balmer, et al.
Plos One|March 10, 2016
HPV Serology Testing Confirms High HPV Immunisation Coverage in EnglandDavid Mesher, Elaine Stanford, Joanne White, et al.
Vaccine|March 23, 2005
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school childrenJamie Findlow, Ann Lowe, Sarah Deane, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccinePaul Balmer, Ray Borrow, Jamie Findlow, et al.
Vaccine|April 17, 2013
Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)Julie A Bettinger, David W Scheifele, Scott A Halperin, et al.
Vaccine|April 3, 2026
Ability of the MenB-fHbp vaccine to provide immune protection against meningococcal serogroup B ST-1161 UK university "South West Outbreak" strain isolatesJay Lucidarme, Stephen A Clark, Ray Borrow, et al.
Clinical and Vaccine Immunology : CVI|December 19, 2008
Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United KingdomJo Southern, Ray Borrow, Nick Andrews, et al.
Clinical and Vaccine Immunology : CVI|November 13, 2009
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccineRay Borrow, Nick Andrews, Helen Findlow, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Human Vaccines & Immunotherapeutics|September 8, 2023
Real-world impact and effectiveness of MenACWY-TTRodolfo Villena, Paula Kriz, Myint Tin Tin Htar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2011
Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccinationJames B Wing, Lynne Smart, Ray Borrow, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2007
Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in EnglandCaroline Trotter, Jamie Findlow, Paul Balmer, et al.
Plos One|March 10, 2016
HPV Serology Testing Confirms High HPV Immunisation Coverage in EnglandDavid Mesher, Elaine Stanford, Joanne White, et al.
Vaccine|March 23, 2005
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school childrenJamie Findlow, Ann Lowe, Sarah Deane, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccinePaul Balmer, Ray Borrow, Jamie Findlow, et al.
Vaccine|April 17, 2013
Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)Julie A Bettinger, David W Scheifele, Scott A Halperin, et al.
Vaccine|April 3, 2026
Ability of the MenB-fHbp vaccine to provide immune protection against meningococcal serogroup B ST-1161 UK university "South West Outbreak" strain isolatesJay Lucidarme, Stephen A Clark, Ray Borrow, et al.
Clinical and Vaccine Immunology : CVI|December 19, 2008
Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United KingdomJo Southern, Ray Borrow, Nick Andrews, et al.
Clinical and Vaccine Immunology : CVI|November 13, 2009
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccineRay Borrow, Nick Andrews, Helen Findlow, et al.
Pageof 10